10X Fund, L.P. - 24 Nov 2025 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Reporting relationship: 10%+ Owner
Issuer ticker: GALT
Reported as of: 24 Nov 2025
Net transaction value: -$204,335
SEC form: 4
Accepted by SEC: 18 Dec 2025, 10:34:54 UTC
Prior SEC filing: 12 Nov 2025
Next SEC filing: 08 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP

Key filing fact

10X Fund, L.P. filed Form 4 for GALECTIN THERAPEUTICS INC (GALT) on 18 Dec 2025.

Key facts

This page summarizes 10X Fund, L.P.'s Form 4 filing for GALECTIN THERAPEUTICS INC (GALT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Dec 2025, 10:34.

Change

Previous filing in this sequence was filed on 12 Nov 2025.
Current net transaction value: -$204,335.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (3)

CIK 0001453356 Primary reporting owner

10X Fund, L.P.

Relationship: 10%+ Owner
Address: 545 DUTCH VALLEY ROAD, N.E., SUITE A, ATLANTA,
Signature: /s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP
Signature date: 18 Dec 2025

CIK 0001457247

10X Capital Management, LLC

Relationship: 10%+ Owner
Address: 545 DUTCH VALLEY ROAD, N.E., SUITE A, ATLANTA,
Signature: /s/ James C. Czirr, as Managing Member of 10X Capital Management, LLC
Signature date: 18 Dec 2025

CIK 0001260641

CZIRR JAMES C

Relationship: 10%+ Owner
Address: 4908 SOUTH ASHTON COURT, SPOKANE
Signature: /s/ James C. Czirr, Individually
Signature date: 18 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GALT transaction

Common Stock

Other

Transaction value
Shares: -24,000
Change %: -0.42%
Price
Shares after: 5,645,138
Date: 24 Nov 2025
Ownership: Direct
Footnotes: F1, F2

GALT transaction

Common Stock

Sale

Transaction value: $204,335
Shares: -30,681
Change %: -0.54%
Price: $6.66
Shares after: 5,614,457
Date: 16 Dec 2025
Ownership: Direct
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law.

Footnote F2

10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Footnote F3

The shares were sold in multiple transactions at prices ranging from $6.64 to $6.69. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.